Here are five things to know:
1. Northland Securities assumed coverage of Stryker shares yesterday.
2. Northland issued an “outperform” rating.
3. They gave a $109 price target on Stryker shares.
4. Argus recently reiterated a “buy” rating at $110 price target.
5. Stryker’s vice president Katherine Ann Owen sold 18,575 shares recently in a $1.7 million transaction.
More articles on orthopedic devices:
LDR gets “Outperform” rating—5 key notes
Spinal Kinetics M6 disc replacement: Good results 2 years postop
Allegheny Health Network incorporates MAKOplasty
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
